Date: 12.7.2023
In a new study, scientists from the University of Queensland have found that the venom found in the bristles of the asp caterpillar (Megalopyge opercularis) can punch holes in cells in the same way that the sickness-causing E. coli and Salmonella bacterial toxins can.
Fascinatingly, the asp has retained this molecular hole-punching trait for more than 400 million years, after acquiring it through a transfer of genes from bacteria. In evolutionary biology terms, it suggests it's a powerful survival mechanism worth holding onto for the species. Now, it could also prove mighty for us, with the potential to use these toxin behaviors to produce cancer-killing treatment and more.
“Toxins that puncture holes in cells have particular potential in drug delivery because of their ability to enter cells,” said Andrew Walker from the Institute for Molecular Bioscience at the University of Queensland (UQ). “There may be a way to engineer the molecule to target beneficial drugs to healthy cells, or to selectively kill cancer cells.”
The asp caterpillar, which has many common names and has even been jokingly called the Donald Trump caterpillar, is the larval form of the Southern flannel moth and is found across the US, predominantly in the southern states.
And it packs a painful sting, delivered by its skin-piercing venom barbs hidden among fuzzy-looking bristles. The side-effects of the sting vary, from a very unpleasant burn-like caterpillar-shaped mark, to more severe reactions that have seen people present to the emergency room.
Image source: Wikimedia Commons, Amizrachi, CC BY-SA 4.0.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Plant biotechnology - Information about plant biotechnology
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Spinning artificial spider silk into next-generation medical materials
Immunotherapy prevents heart attacks progressing to heart failure